Exagen, Inc. (XGN)
6.08
+0.07
(+1.16%)
USD |
NASDAQ |
Dec 31, 16:00
6.10
+0.02
(+0.33%)
After-Hours: 20:00
Exagen Cash from Investing (Quarterly): -0.275M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| FONAR Corp. | -2.367M |
| XWELL, Inc. | 1.715M |
| ProPhase Labs, Inc. | 0.00 |
| Veracyte, Inc. | 48.26M |
| Insight Molecular Diagnostics, Inc. | -1.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.944M |
| Cash from Financing (Quarterly) | 2.95M |
| Free Cash Flow | -10.99M |
| Free Cash Flow Per Share (Quarterly) | 0.1163 |
| Free Cash Flow to Equity (Quarterly) | -0.294M |
| Free Cash Flow to Firm (Quarterly) | 3.988M |
| Free Cash Flow Yield | -8.93% |